13,600 Shares in Doximity, Inc. (NASDAQ:DOCS) Acquired by Schonfeld Strategic Advisors LLC

Schonfeld Strategic Advisors LLC bought a new stake in shares of Doximity, Inc. (NASDAQ:DOCS) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 13,600 shares of the company’s stock, valued at approximately $726,000.

Other institutional investors have also added to or reduced their stakes in the company. Shaker Investments LLC OH bought a new position in Doximity in the 4th quarter worth $559,000. Principal Financial Group Inc. raised its stake in shares of Doximity by 1.5% in the fourth quarter. Principal Financial Group Inc. now owns 293,974 shares of the company’s stock worth $15,695,000 after buying an additional 4,282 shares during the period. Newbridge Financial Services Group Inc. purchased a new position in shares of Doximity during the 4th quarter valued at about $362,000. Stratos Wealth Partners LTD. bought a new position in shares of Doximity during the 4th quarter valued at approximately $203,000. Finally, Wells Fargo & Company MN raised its stake in Doximity by 3.3% during the 4th quarter. Wells Fargo & Company MN now owns 368,941 shares of the company’s stock worth $19,698,000 after acquiring an additional 11,811 shares during the period. 87.19% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

DOCS has been the subject of a number of analyst reports. Wells Fargo & Company reissued an “equal weight” rating on shares of Doximity in a research note on Friday, February 7th. Truist Financial decreased their price target on Doximity from $65.00 to $58.00 and set a “hold” rating on the stock in a report on Thursday, April 10th. Leerink Partnrs raised Doximity from a “hold” rating to a “strong-buy” rating in a research note on Friday, February 7th. Canaccord Genuity Group lifted their target price on Doximity from $60.00 to $71.00 and gave the company a “hold” rating in a research note on Friday, February 7th. Finally, Mizuho boosted their price target on Doximity from $55.00 to $65.00 and gave the stock a “neutral” rating in a report on Monday, February 10th. Eleven equities research analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $65.39.

Doximity Trading Down 0.4 %

Shares of DOCS opened at $59.10 on Friday. The company’s fifty day simple moving average is $57.99 and its 200-day simple moving average is $57.14. The company has a market cap of $11.03 billion, a P/E ratio of 59.10, a P/E/G ratio of 4.10 and a beta of 1.41. Doximity, Inc. has a twelve month low of $22.96 and a twelve month high of $85.21.

Insider Buying and Selling

In other news, Director Kira Scherer Wampler sold 2,000 shares of Doximity stock in a transaction on Thursday, May 1st. The stock was sold at an average price of $56.93, for a total transaction of $113,860.00. Following the completion of the sale, the director now directly owns 16,618 shares in the company, valued at approximately $946,062.74. This trade represents a 10.74 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Anna Bryson sold 45,000 shares of the company’s stock in a transaction dated Thursday, May 1st. The stock was sold at an average price of $57.23, for a total transaction of $2,575,350.00. Following the completion of the transaction, the chief financial officer now owns 357,165 shares in the company, valued at approximately $20,440,552.95. The trade was a 11.19 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 37.40% of the stock is currently owned by corporate insiders.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.